Cytokinetics (CYTK) Non Operating Income (2010 - 2026)
Cytokinetics (CYTK) reported Non Operating Income of $13.94 million for Q2 2026, up 7.2% from $13 million a year earlier and up 26.5% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Non Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cytokinetics' Non Operating Income came in at $46.68 million, down 20.6% year-over-year; for FY2025, it came in at $48.42 million, down 6.0% from FY2024.
- Non Operating Income has a five-year compound annual growth rate of 55.5% (FY2020 to FY2025).
- By year, Non Operating Income came in at $51.53 million in FY2024 (+86.5%), $27.63 million in FY2023 (+143.6%), $11.34 million in FY2022 and $331,000 in FY2021 (-93.8%).
- The Q2 2026 figure ranks as the highest quarterly Non Operating Income since Q4 2024.
- Year over year, Non Operating Income gained in five of the last eight quarters, with growth averaging 32.1%.
- The high point for year-over-year Non Operating Income in five years was Q2 2023 (growth of 684.6%); the low point was Q3 2021 (a decline of 78.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.02 million (Q1 2026), $11.47 million (Q4 2025) and $10.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Cytokinetics | 9.16 Bn | 5.33 Bn | 25.89 Mn | 13.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.94 Mn |
| Mar 31, 2026 | 11.02 Mn |
| Dec 31, 2025 | 11.47 Mn |
| Sep 30, 2025 | 10.25 Mn |
| Jun 30, 2025 | 13.00 Mn |
| Mar 31, 2025 | 13.70 Mn |
| Dec 31, 2024 | 15.01 Mn |
| Sep 30, 2024 | 17.05 Mn |
| Jun 30, 2024 | 11.55 Mn |
| Mar 31, 2024 | 7.91 Mn |
| Dec 31, 2023 | 7.59 Mn |
| Sep 30, 2023 | 6.84 Mn |
| Jun 30, 2023 | 6.78 Mn |
| Mar 31, 2023 | 6.43 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 864,000.00 |
| Mar 31, 2022 | 415,000.00 |
| Dec 31, 2021 | -377,000.00 |
| Sep 30, 2021 | 231,000.00 |
API Access
Cytokinetics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();